ADC Platform: In Vitro ADC Functional Testing | Kyinno

In Vitro ADC Testing

ADC Functional Testing Platform

This ADC platform is an in vitro testing service that evaluates target engagement, internalization, and cytotoxic activity of antibody-drug conjugate candidates in cell-based assays.

Five assay groups

  1. 1Binding Activity
  2. 2Cross-Species and Knockout Validation
  3. 3Internalization
  4. 4Bystander Effect
  5. 5Cytotoxicity

Service Overview

In Vitro ADC Functional Testing Overview

The development of Antibody-Drug Conjugates (ADCs) is a complex engineering process. We have established a comprehensive in vitro functional testing platform covering the entire Mechanism of Action (MOA)—from protein binding and cellular recognition to internalization efficiency and final cytotoxic effects —providing precise data for candidate screening and optimization.

Schematic of ADC components and the pathway from receptor binding through internalization to intracellular delivery of the cytotoxic drug.

Binding Activity

Evaluation of ADC Binding Activity

Binding is the first step for ADCs to exert targeted therapy.

Protein-Level Binding by ELISA

Quantitatively measure the affinity and specificity between ADCs and purified antigen proteins using high-throughput, high-sensitivity ELISA.

Example ELISA binding curves for antibody samples across a concentration range.

Cell-Level Binding by Flow Cytometry

Evaluate binding capacity in the native cellular membrane environment using Flow Cytometry (FACS) for a more realistic reflection of biological recognition.

Example flow cytometry binding curves for antibody samples on target-expressing cells.

Specificity

Cross-Species Reactivity and Preliminary Off-Target Validation

Two cell-engineering approaches address species relevance and target dependence, supporting antibody-drug conjugate testing before animal studies are planned.

Multi-Species Cell Models

We construct cell lines expressing target antigens from various species (e.g., human, monkey, mouse) to assess cross-species reactivity, providing  a scientific basis for selecting animal toxicology models.

Example engineered cell models expressing CCR8 from human, cynomolgus monkey, and mouse, with B7H3 expression panels.

Knockout Validation (Preliminary Off-Target)

Utilizing advanced gene editing we construct Target Knockout (KO) cell lines. By comparing binding and killing differences between Wild-Type (WT) and KO cells, we verify target specificity and rule out non-specific off-target risks.

Example validation of TROP2 and B7H3 knockout cell lines by sequencing and flow cytometry.

Internalization

Comprehensive Internalization Assays

Internalization is the key step for ADCS to deliver the payload. 

Stripping Assay

Precisely distinguish and quantify internalized ADCs by stripping un-internalized antibodies from the cell surface using acidic buffers.

pHrodo-Based Internalization Assay

Label ADCs with pH-sensitive dyes. Fluorescence intensifies in the acidic environment of endosomes/lysosomes. We offer both Flow Cytometry (quantitative and Live-Cell Imaging (visualization) modes.

DT3C Enzymatic Reporter Assay

A wash-free method with high signal-to-noise ratio. The DT3C enzyme is released upon lysosomal degradation of the ADC, generating a fluorescent signal.

Reserved for an illustration of internalization assay concepts.

Bystander Effect

Bystander Effect Evaluation

To address tumor heterogeneity, we simulate the in vivo tumor microenvironment using co-cultures if Antigen-Positive (Ag+) and Antigen-Negative (Ag-) cells (fluorescently labeled). This assay precisely quantifies the killing ability of the payload on Ag- cells, evaluating linker stability and membrane permeability.

Co-culture schematic and example data for bystander effect evaluation with ADC and isotype control conditions.

Cytotoxicity

Cytotoxicity Evaluation

To verify the antitumor activity and efficacy of the drug payload, we evaluate the in vitro cytotoxic performance of the agent via mono-culture of tumor cells. This assay accurately detects, assessing the overall antitumor potency, drug bioactivity and effective cell killing efficiency of the conjugate.

Reserved for a figure illustrating the cytotoxicity evaluation of ADC candidates.

Why Kyinno

Why Work With Kyinno

The service pairs a defined set of functional assays with in-house cell engineering.

  • Five assay groups cover binding, specificity, internalization, bystander activity, and cytotoxicity for the same candidate.
  • Cell lines expressing human, monkey, and mouse target antigens support cross-species assessment.
  • Gene-edited target knockout cell lines allow wild-type and knockout responses to be compared.

Discuss Your ADC Testing Project

Share your target, candidate format, and study goals, and the Kyinno team will help identify which assays fit your ADC platform evaluation.